Episode 23020
A Different Approach, A New Cancer Drug... Dr. Paul Lammers, CEO Triumvira Immunologics
BioTech Nation ... with Dr. Moira Gunn · Moira Gunn
May 17, 202313m 31s
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Cancer treatments which work with the immune system are making great strides, with Keytruda from Merck being perhaps the best known. Still there is much work to be done – both in developing unprecedented new treatments, as well as treatments which might combine with our existing treatments to make them even more effective. Triumvera (try-um-VEERA) Immunologics is working on both. Dr. Paul Lammers is its CEO.
Topics
CancerTherapeuticsTriumvera ImmunologicsPaul LammersMoira GunnBioTech NationBiotech